Eli Lilly has lined up another deal in the radiopharmaceutical sector, paying $140 million to partner drugs developed by Radionetics Oncology and taking an option on buying the company outright for $1 ...
Novartis has struck another deal to strengthen its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology. The deal also includes ...
Space.com on MSN
What is the weak nuclear force and why is it important?
The weak nuclear force doesn't play by the normal rules — and, in fact, it breaks one of the biggest rules of all.
A new study shows that a single injection of specially designed nanoparticles can dramatically reduce levels of a toxic ...
The melanoma market is expected to witness sustained growth driven by continuous therapeutic innovation and wider patient access. Advances in immunotherapies and targeted treatments, along with ...
Chen-Ning “C.N.” Yang, a Nobel Prize-winning physicist and founder of Stony Brook University’s C.N. Yang Institute for Theoretical Physics, died in Beijing, China at 103 years old on Saturday, Oct. 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results